Parabilis Medicines Shatters Records with Historic $770.5 Million IPO, Signaling Biotech Resurgence
In a watershed moment for the life sciences sector, Cambridge-based Parabilis Medicines (Nasdaq: PBLS) has officially cemented its position at...
In a watershed moment for the life sciences sector, Cambridge-based Parabilis Medicines (Nasdaq: PBLS) has officially cemented its position at...